Hinge Health, Inc.
Price Action
Technical Summary
EMERGING TRENDHinge Health, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings contraction of 74% provides fundamental context to the price action. However, with RSI at 81, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $65.76 | +20.09% | ABOVE |
| 50 SMA | $56.38 | +40.06% | ABOVE |
| 100 SMA | $48.29 | +63.52% | ABOVE |
| 150 SMA | $47.52 | +66.20% | ABOVE |
| 200 SMA | $48.25 | +63.66% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HNGE in an uptrend right now?
HNGE has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is HNGE overbought or oversold?
HNGE's RSI (14) is 81. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is HNGE outperforming the market?
HNGE has a Relative Strength (RS) Rating of 94 out of 99. Yes, HNGE is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is HNGE in its 52-week range?
HNGE is trading at $78.97, which is 100% of its 52-week high ($79.26) and 99% above its 52-week low ($30.08).
How volatile is HNGE?
HNGE has a Beta of 1.29 and 52-week volatility of 63%. It's more volatile than the S&P 500 - expect bigger swings.